Therapeutic use of stem cell transplantation for cell replacement or cytoprotective effect of microvesicle released from mesenchymal stem cell

Molecules and Cells

Volumn 37, Issue 2, 2014, Pages 133-139

  Choi, Moonhwan ^a   Ban, Taehyun ^a   Rhim, Taiyoun ^a  

^a Hanyang University   (South Korea)

Author keywords

Idiopathic pulmonary fibrosis; Mesenchymal stem cell; Stem cell derived microvesicle

Indexed keywords

COLLAGEN; SURFACTANT ASSOCIATED PROTEIN; CONDITIONED MEDIUM;

ANIMAL EXPERIMENT; ARTICLE; BONE MARROW; CELL DIFFERENTIATION; CELL PROTECTION; CELL TYPE; CELL VACUOLE; CONTROLLED STUDY; FEMALE; FIBROSING ALVEOLITIS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; LUNG ALVEOLUS CELL; LUNG FIBROSIS; LUNG FUNCTION; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; MICROVESICLE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THERAPY EFFECT; ANIMAL; BRONCHOALVEOLAR LAVAGE FLUID; CELL CULTURE; CHEMISTRY; CONDITIONED MEDIUM; CYTOLOGY; DISEASE MODEL; EXOSOME; IDIOPATHIC PULMONARY FIBROSIS; IMMUNOLOGY; LUNG; MESENCHYMAL STROMA CELL; PATHOLOGY; PHARMACOLOGY; PHYSIOLOGY; PROCEDURES; TRANSPLANTATION;

ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; CELL DIFFERENTIATION; CELLS, CULTURED; CULTURE MEDIA, CONDITIONED; DISEASE MODELS, ANIMAL; EXOSOMES; FEMALE; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; LUNG; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICE;

EID: 84901475978     PISSN: 10168478     EISSN: 02191032     Source Type: Journal    
DOI: 10.14348/molcells.2014.2317     Document Type: Article

References (22)

1. Akao, Y., Iio, A., Itoh, T., Noguchi, S., Itoh, Y., Ohtsuki, Y., and Naoe, T. (2011). Microvesicle-mediated RNA molecule delivery system using monocytes/macrophages. Mol. Ther. 19, 395-399.
2. Banerjee, E.R., Laflamme, M.A., Papayannopoulou, T., Kahn, M., Murry, C.E., and Henderson, W.R., Jr. (2012). Human embryonic stem cells differentiated to lung lineage-specific cells ameliorate pulmonary fibrosis in a xenograft transplant mouse model. PLoS One 7, e33165.
3. Bedrossian, C., Warren, C., Ohar, J., and Jackson, F. (1991). Amiodarone pulmonary toxicity - cytopathology ultrastructure and immunocytochemistry. Lab. Invest. 64, A113-A113.
4. Camussi, G., Deregibus, M.C., Bruno, S., Cantaluppi, V., and Biancone, L. (2010). Exosomes/microvesicles as a mechanism of cell-to-cell communication. Kidney Int. 78, 838-848.
5. Guttentag, S.H., Beers, M.F., Bieler, B.M., and Ballard, P.L. (1998). Surfactant protein B processing in human fetal lung. Am. J. Physiol. 275, L559-566.
6. Ha, Y., Shin, J.S., Lee, D.Y., and Rhim, T. (2012). Fluorescently labeled nanoparticles enable the detection of stem cell-derived hepatocytes. B Korean Chem. Soc. 33, 1983-1988.
7. Hu, G., Drescher, K.M., and Chen, X.M. (2012). Exosomal miRNAs: biological properties and therapeutic potential. Front. Genet. 3, 56.
8. Iyer, S.N., Gurujeyalakshmi, G., and Giri, S.N. (1999). Effects of pirfenidone on transforming growth factor-beta gene expression at the transcriptional level in bleomycin hamster model of lung fibrosis. J. Pharmacol. Exp. Ther. 291, 367-373. (Pubitemid 29451612)
9. Kim, T.H., Lee, Y.H., Kim, K.H., Lee, S.H., Cha, J.Y., Shin, E.K., Jung, S., Jang, A.S., Park, S.W., Uh, S.T., et al. (2010). Role of lung apolipoprotein A-I in idiopathic pulmonary fibrosis: antiinflammatory and antifibrotic effect on experimental lung injury and fibrosis. Am. J. Respir. Crit. Care Med. 182, 633-642.
10. King, T.E., Jr., Tooze, J.A., Schwarz, M.I., Brown, K.R., and Cherniack, R.M. (2001). Predicting survival in idiopathic pulmonary fibrosis: scoring system and survival model. Am. J. Respir. Crit. Care Med. 164, 1171-1181. (Pubitemid 33052246)
11. Lee, S.H., Jang, A.S., Kim, Y.E., Cha, J.Y., Kim, T.H., Jung, S., Park, S.K., Lee, Y.K., Won, J.H., Kim, Y.H., et al. (2010). Modulation of cytokine and nitric oxide by mesenchymal stem cell transfer in lung injury/fibrosis. Respir. Res. 11, 16.
12. Liu, T.J., Chung, M.J., Ullenbruch, M., Yu, H.F., Jin, H., Hu, B., Choi, Y.Y., Ishikawa, F., and Phan, S.H. (2007). Telomerase activity is required for bleomycin-induced pulmonary fibrosis in mice. J. Clin. Invest. 117, 3800-3809. (Pubitemid 350224090)
13. Luppi, F., Spagnolo, P., Cerri, S., and Richeldi, L. (2012). The big clinical trials in idiopathic pulmonary fibrosis. Curr. Opin. Pulm. Med. 18, 428-432.
14. Moore, B.B., and Hogaboam, C.M. (2008). Murine models of pulmonary fibrosis. Am. J. Physiol. Lung C 294, L152-L160. (Pubitemid 351253350)
15. Ortiz, L.A., Gambelli, F., McBride, C., Gaupp, D., Baddoo, M., Kaminski, N., and Phinney, D.G. (2003). Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects. Proc. Natl. Acad. Sci. USA 100, 8407-8411. (Pubitemid 36842558)
16. Raghu, G., Collard, H.R., Egan, J.J., Martinez, F.J., Behr, J., Brown, K.K., Colby, T.V., Cordier, J.F., Flaherty, K.R., Lasky, J.A., et al. (2011). An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am. J. Respir. Crit. Care Med. 183, 788-824.
17. Selman, M., King, T.E., Pardo, A., American Thoracic, S., European Respiratory, S., and American College of Chest, P. (2001). Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy. Ann. Int. Med. 134, 136-151. (Pubitemid 32096342)
18. Steele, M.P., and Schwartz, D.A. (2012). Molecular mechanisms in progressive idiopathic pulmonary fibrosis. Ann. Rev. Med. 64, 265-276.
19. Szade, K., Zuba-Surma, E., Rutkowski, A.J., Jozkowicz, A., and Dulak, J. (2011). CD45-CD14 +CD34 + murine bone marrow low-adherent mesenchymal primitive cells preserve multilineage differentiation potential in long-term in vitro culture. Mol. Cells 31, 497-507.
20. Taniguchi, H., Ebina, M., Kondoh, Y., Ogura, T., Azuma, A., Suga, M., Taguchi, Y., Takahashi, H., Nakata, K., Sato, A., et al. (2010). Pirfenidone in idiopathic pulmonary fibrosis. Eur. Respir. J. 35, 821-829.
21. Zhao, F., Zhang, Y.F., Liu, Y.G., Zhou, J.J., Li, Z.K., Wu, C.G., and Qi, H.W. (2008). Therapeutic effects of bone marrow-derived mesenchymal stem cells engraftment on bleomycin-induced lung injury in rats. Transplant. Proc. 40, 1700-1705. (Pubitemid 351853229)
22. Zhao, M.M., Cui, J.Z., Cui, Y., Li, R., Tian, Y.X., Song, S.X., Zhang, J., and Gao, J.L. (2013). Therapeutic effect of exogenous bone marrowderived mesenchymal stem cell transplantation on silicosis via paracrine mechanisms in rats. Mol. Med. Rep. 8, 741-746.